Allstate Corp Kodiak Sciences Inc. Transaction History

Allstate Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$80.85 - $128.49 $185,146 - $294,242	-2,290 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $154 - $253	2 Added 0.09%	2,290 $213,000
Q4 2020 Feb 12, 2021	SELL	$60.78 - $154.03 $105,088 - $266,317	-1,729 Reduced 43.04%	2,288 $336,000
Q3 2020 Nov 13, 2020	BUY	$45.05 - $59.27 $405 - $533	9 Added 0.22%	4,017 $238,000
Q2 2020 Aug 13, 2020	BUY	$42.74 - $66.25 $171,301 - $265,530	4,008 New	4,008 $217,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $303M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.